Abstract
With a drug company funded conference on prehypertension set to take place next year, Ray Moynihan examines the emergence of this controversial new classification
| Original language | English |
|---|---|
| Pages (from-to) | 484-485 |
| Number of pages | 4 |
| Journal | BMJ (Online) |
| Volume | 341 |
| Issue number | 7771 |
| DOIs | |
| Publication status | Published - 4 Sept 2010 |
Fingerprint
Dive into the research topics of 'Prediseases: Who benefits from treating prehypertension?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver